Pyrazolyl derivatives as inhibitors of the KRAS mutant protein

The present invention provides a compound of formula (I), or a pharmaceutically acceptable salt thereof, Formula (I), and the therapeutic uses of said compound. The present invention further provides a pharmaceutical composition comprising said compound.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MAH, ROBERT, RIGOLLIER, PASCAL, BRACHMANN, SASKIA MARIA, WILCKEN, RAINER, ZECRI, FREDERIC, LEBLANC, CATHERINE, BOMIO-CONFAGLIA, CLAUDIO, VAUPEL, ANDREA, COTESTA, SIMONA, GERSPACHER, MARC, LIMA, FABIO, RACINE, SOPHIE, WARIN, NICOLAS, MACHAUER, RAINER, STUTZ, STEFAN, LORTHIOIS, EDWIGE LILIANE JEANNE
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention provides a compound of formula (I), or a pharmaceutically acceptable salt thereof, Formula (I), and the therapeutic uses of said compound. The present invention further provides a pharmaceutical composition comprising said compound.